iifl-logo-icon 1

Vilin Bio Med Ltd Board Meeting

19
(-5.47%)
Mar 3, 2025|12:00:00 AM

Vilin Bio Med CORPORATE ACTIONS

07/03/2024calendar-icon
07/03/2025calendar-icon
PurposeBoard Meetings DateAnnouncement Date
Board Meeting23 Jan 202523 Jan 2025
Vilin Bio Med Limited has informed the Exchange regarding Board meeting held on January 23, 2025. (As Per NSE Announcement Dated on: 23/01/2025)
Board Meeting10 Jan 20254 Jan 2025
To consider Fund Raising and other business matters Vilin Bio Med Limited has informed the Exchange regarding Board meeting held on January 10, 2025. (As Per NSE Announcement Dated on: 10/01/2025) Due to omission on our part, we are here by submitting the outcome of the board meeting for your record (As Per NSE Announcement Dated on: 22.01.2025)
Board Meeting30 Oct 202423 Oct 2024
To consider and approve the financial results for the period ended September 30, 2024 Vilin Bio Med Limited has informed the Exchange regarding Board meeting held on October 30, 2024. (AS Per NSE Announcement Dated on: 30/10/2024)
Board Meeting3 Oct 20243 Oct 2024
Vilin Bio Med Limited has informed the Exchange regarding Appointment of Mr. Yadamakanti Madhu Sudhan Reddy as Managing Director of the company w.e.f. October 03, 2024.
Board Meeting22 Aug 202416 Aug 2024
To consider matters related to the Annual General Meeting and other business matters Vilin Bio Med Limited has informed the Exchange regarding Outcome of Board Meeting held on August 22, 2024. (As Per NSE Announcement Dated on: 22/08/2024)
Board Meeting29 May 202420 May 2024
To consider and approve the financial results for the period ended March 31, 2024 Vilin Bio Med Limited has informed the Exchange regarding Board meeting held on May 29, 2024. (As Per NSE Announcement Dated on: 29/05/2024)
Board Meeting4 May 20244 May 2024
The Board of Directors of the Company at their meeting held today has Appointed Mr. ANAND LOHIA (Membership No: A48220) as Company Secretary and Compliance Officer of the Company w.e.f. May 04, 2023, in pursuant to Section 203 of Companies Act, 2013 and under Regulation 6 of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015.

Vilin Bio Med: Related News

No Record Found

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Securities Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248

plus
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.